Complete response of hepatocellular carcinoma with sorafenib and (90)Y radioembolization

Advanced hepatocellular carcinoma has a dismal prognosis, with a median overall survival of 7.9 months if untreated and of 10.7 months if treated with sorafenib. We present a case of advanced previously unresectable hepatocellular carcinoma in a 49-year-old man that achieved a pathologic complete re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chaudhury, P.K., Hassanain, M., Bouteaud, J.M., Alcindor, T., Nudo, C.G., Valenti, D., Cabrera, T., Kavan, P., Feteih, I., Metrakos, P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Multimed Inc. 2010
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2949375/
https://ncbi.nlm.nih.gov/pubmed/20975882
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak